Physician profile
John H Eilbert
NPI 1477644433
$1,103.13
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $189 · 2021: $297 · 2022: $37.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $159.57 | 2019-2022 | |
| Boston Scientific Corporation | $149.28 | 2019-2021 | |
| Glaxosmithkline, LLC. | $146.48 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $79.51 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.22 | 2019-2021 | |
| Abbott Laboratories | $65.31 | 2020-2022 | |
| Insmed, INC. | $54.88 | 2019-2021 | |
| Allergan, INC. | $45.67 | 2020 | |
| Abbvie INC. | $44.75 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $39.28 | 2019 | |
| Tersera Therapeutics LLC | $34.66 | 2019 | |
| Pfizer INC. | $30.19 | 2019 | |
| Nevro Corp. | $29.06 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.89 | 2019 | |
| Orexo US, INC. | $23.82 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.15 | 2019 | |
| Mylan Specialty L.P. | $16.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.66 | 2020 | |
| Kaleo, INC. | $15.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.41 | 2020 | |
| Electromed, INC. | $13.50 | 2019 | |
| Avanos Medical | $11.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.